| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |